Skip to main content
logo
Towa Pharmaceutical Co., Ltd. (TYO:4553)
Japan flag Japan · Delayed Price · Currency is JPY
3,870.00
-40.00 (-1.02%)
Aug 4, 2026, 11:13 AM JST

Towa Pharmaceutical Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
192,481197,158131,879142,93393,275135,736
Market Cap Growth
19.57%49.50%-7.73%53.24%-31.28%12.90%
Enterprise Value
376,127390,997326,106308,406222,967195,152
Last Close Price
3910.004005.002618.172770.631771.342492.57

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
36.6637.556.958.8442.388.53
Forward PE
8.579.788.3711.9911.968.06
PS Ratio
0.700.720.510.630.450.82
PB Ratio
1.081.110.770.920.681.03
P/TBV Ratio
1.271.301.051.361.111.74
P/FCF Ratio
23.6124.19---12.35
P/OCF Ratio
6.336.485.6417.4136.676.13
PEG Ratio
0.135.585.585.585.587.28

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
1.371.431.261.351.071.18
EV/EBITDA Ratio
8.198.517.528.688.956.62
EV/EBIT Ratio
16.2816.9214.0317.4840.4310.53
EV/FCF Ratio
46.1447.96---17.76

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
1.291.291.381.321.261.09
Debt / EBITDA Ratio
4.984.985.455.806.944.89
Debt / FCF Ratio
28.0928.09---13.12
Net Debt / Equity Ratio
1.031.031.111.131.090.84
Net Debt / EBITDA Ratio
4.004.004.404.975.973.77
Net Debt / FCF Ratio
22.5322.53-35.78-5.96-5.6810.13
Asset Turnover
0.580.580.580.570.600.57
Inventory Turnover
1.511.511.581.511.641.43
Quick Ratio
1.231.231.331.261.000.73
Current Ratio
2.762.762.812.722.331.45
Return on Equity (ROE)
3.00%3.00%11.59%11.05%1.64%12.79%
Return on Assets (ROA)
3.05%3.05%3.22%2.75%0.98%4.03%
Return on Invested Capital (ROIC)
2.47%2.54%4.82%3.78%1.00%6.29%
Return on Capital Employed (ROCE)
6.10%6.10%6.10%5.00%1.90%8.60%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
2.73%2.66%14.40%11.31%2.36%11.72%
FCF Yield
4.24%4.13%-4.04%-20.74%-28.07%8.10%
Dividend Yield
2.12%2.00%2.67%2.17%3.39%2.29%
Payout Ratio
75.01%74.99%15.55%18.25%140.84%15.15%
Buyback Yield / Dilution
-0.01%-0.01%-0.01%0.00%2.19%1.86%
Total Shareholder Return
2.12%1.99%2.67%2.17%5.58%4.15%